HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Ngui Selected Research

Daniel Ngui Research Topics

Disease

3Stroke (Strokes)
06/2022 - 12/2020
2Atrial Fibrillation
01/2022 - 12/2020
2Atherosclerosis
01/2021 - 11/2016
2Chronic Renal Insufficiency
01/2021 - 11/2016
2Abdominal Aortic Aneurysm
01/2021 - 11/2016
2Osteoporosis
04/2014 - 03/2013
1Hypertriglyceridemia
01/2022
1Embolic Stroke
01/2022
1Patent Foramen Ovale
01/2022
1Hyperlipidemias (Hyperlipidemia)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Hemorrhage
12/2020
1Osteonecrosis (Kienbock's Disease)
04/2014
1Postmenopausal Osteoporosis
03/2013
1Osteoporotic Fractures
03/2013

Drug/Important Bio-Agent (IBA)

2AnticoagulantsIBA
01/2022 - 12/2020
2LDL CholesterolIBA
01/2021 - 11/2016
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2021 - 11/2016
2Diphosphonates (Bisphosphonates)IBA
04/2014 - 03/2013
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2022
1Vitamin KFDA Link
12/2020
1N(4)-oleylcytosine arabinosideIBA
12/2020
1CreatinineIBA
12/2020
1Pharmaceutical PreparationsIBA
04/2014
1Raloxifene Hydrochloride (Evista)FDA Link
03/2013
1Teriparatide (Parathar)FDA Link
03/2013
1Hormones (Hormone)IBA
03/2013
1DenosumabFDA Link
03/2013

Therapy/Procedure

5Therapeutics
01/2022 - 03/2013
2Secondary Prevention
06/2022 - 01/2022
2Drug Therapy (Chemotherapy)
12/2020 - 03/2013